AMIVAAMIVA Equity Partners
Confidential

Specialty Dental Platform Near Major Metro

A confidential sale run by AMIVA Equity Partners, on deal ai.

Revenue$6.5M
Adj. EBITDA$1.05M
EBITDA Margin16.2%
Locations2
Dentists7

$6.5M

Revenue · TTM

$1.1M

Adj. EBITDA · Normalized

  1. Your email

  2. Sign the NDA

  3. Enter the data room

Access this opportunity

Any email works. If we've worked together before, your details will be ready.

New to deal rooms? Take the 2-minute tour

Opportunity overview

AMIVA Equity Partners has been retained to advise on the sale of a two-office dental platform located approximately 70 miles from a top-30 U.S.

metro area in Pennsylvania. The Company offers a differentiated clinical model featuring in-house IV sedation with dental anesthesiologists and hospital dentistry under a written facility agreement — capabilities rarely found outside urban DSO networks. With nearly two decades of operating history, a full complement of seven dentists (five with 8+ years of tenure), and deep community trust, the platform provides a compelling foundation for continued growth. Current ownership, which acquired the practice in September 2025, re-engineered the operating model within twelve months — migrating to a cloud-based practice management system, implementing daily KPI dashboards, consolidating supply vendors, and right-sizing the cost structure. These initiatives drove Adjusted EBITDA from approximately $0.23M (5.3% margin) under prior ownership to $1.05M (16.2% margin) in the first full fiscal year, with an additional ~$171K of identified pro forma upside from billing insourcing. Multiple organic growth levers remain, including payer-mix optimization, implant capacity expansion, and geographic expansion into seven surrounding underserved counties.

Key highlights

  • Adjusted EBITDA of $1.05M (16.2% margin), up from $0.23M (5.3%) under prior ownership — a demonstrated step-change in profitability
  • Clinical moat: in-house IV sedation and hospital dentistry keep complex, higher-margin cases in-house rather than referring out
  • Seven dentists with strong tenure (five at 8+ years) and a robust recruiting pipeline through university affiliations approximately one hour away
  • Significant payer-mix upside: Medicaid currently ~44% of production, with implants, hospital cases, and fee renegotiation as levers to shift toward commercial and self-pay
  • Proximity to a 2.4M-person metro area draws patients from approximately seven surrounding counties and across state lines
  • Re-engineered platform with cloud-based systems, daily KPI visibility, and consolidated vendor relationships — ready for day-one integration by a DSO or strategic acquirer

The non-disclosure agreement

Read it now if you like. You'll see it in full before you sign.

View NDA